From Planning to Implementation: Lessons Learned on Budgeting for CAR T-cell Therapy-From Planning to Implementation_ Lessons Learned on Budgeting for CAR T-cell Therapy

Video Transcription

Video Summary

The webinar focused on how community cancer centers can budget for and implement CAR T-cell therapy successfully. Lindsay Ridgeway introduced the ACCC “Bringing CAR T Cell Therapies to Community Oncology” initiative and its goals: identifying needed resources, building operational infrastructure, and learning practical steps for continuous improvement.<br /><br />Rob Richards presented Penn Medicine’s hub-and-spoke model for expanding CAR T from academic centers into community hospitals. He emphasized detailed process maps covering the full patient journey, standardization with site-specific flexibility, and low-cost operational strategies such as third-party apheresis and just-in-time delivery. He highlighted key implementation areas: legal contracting, pro formas, payer engagement, and risk mitigation. He also stressed that asking questions and documenting everything are essential.<br /><br />During the panel discussion, Tracy Coyne and Becky Dameron Jennings discussed the importance of collaboration across clinical, financial, operational, pharmacy, legal, IT, and managed care teams. They explained how single case agreements, REMS training, staffing, and financial counseling are critical to program success. The panel also addressed patient financial toxicity, travel and lodging barriers, community resources, and the need for continuous insurance verification.<br /><br />Overall, the discussion underscored that CAR T programs require strong leadership, cross-functional teamwork, careful planning, and ongoing communication to expand access while protecting patients and institutions.

Meta Tag

CAR T 1

CAR T-cell therapy 1

Operationalizing 1

Planning 1

Keywords

CAR T-cell therapy

community oncology

budget planning

hub-and-spoke model

operational infrastructure

payer engagement

cross-functional teamwork

patient financial toxicity

insurance verification

1